Loading
CC
Cambrex Corp Stock: price and insider trades · United States
Cambrex Corp: what insiders have been doing
Cambrex Corp is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Cambrex Corp has published a filing in the past twelve months. The most recent one dates from 12 February 2016.
For comparison within the same market, see the insider buying recorded at Relmada Therapeutics, Inc. and Uber Technologies, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
5 ops. · all time
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
RevenueUS$445.8M
Gross profitUS$170.3M38% margin
Net incomeUS$80M17.9% margin
Last declaration on 12 February 2016
Declarations8 total
1,222 sharesCommon StockSEC:0000820081-16-000036:2
72,000 sharesCommon StockSEC:0000820081-16-000037:0
39,542 sharesCommon StockSEC:0000820081-16-000037:1
36,000 sharesCommon StockSEC:0000820081-16-000038:0
15,385 sharesCommon StockSEC:0000820081-16-000038:1
2,957 sharesCommon StockSEC:0000820081-16-000038:2
27,000 sharesCommon StockSEC:0000820081-16-000036:0
12,400 sharesCommon StockSEC:0000820081-16-000036:1
8 of 8 declarations
About Cambrex Corp
Cambrex Corp is a company specializing in the manufacture of chemical and pharmaceutical products. It provides development and manufacturing services for the biopharmaceutical industry.
